Ipsita Smolinski, MBA

Washington, ,DC, Virginia, United States
Ipsita Smolinski is a strategic advisor to the biopharmaceutical, healthcare payor/provider and institutional investor industries. Smolinski, with over twenty years of experience in healthcare policy and economic analysis. analyzes healthcare regulations and legislation for the business impact, along with highlighting overlooked trends and policies that pack a punch, and may be overlooked.

As the Managing Director of Capitol Street, she advises clients on key trends and major actions coming out of Washington, DC via succinct bulleted memos and lengthier analyses, as needed. These include healthcare legislation moving on Capitol Hill, actions from CMS, FDA, NIH, FTC, and other agencies, and emerging politics. We cover the important issues in Federal and State policy that drive the business of healthcare for pharmaceuticals, biotech, supply chain, payers & providers, and medical technology. We factor commercial and employer trends into our unique research product. Our goal is to help our clients understand the most impactful policy and market trends so clients can thread the needle and comprehensively plan for what is ahead.

Smolinski holds a faculty appointment at the Johns Hopkins University Carey Business School where she teaches coursework in Healthcare Economics and Healthcare Finance.

She serves as a Senior Strategic Advisor to McAllister & Quinn, a healthcare firm that supports large U.S. hospital systems.

Smolinski is a frequent speaker at national conferences and appears on CNBC, MSNBC, Fox News and others. She has been quoted in leading publications such as The New York Times, The Wall Street Journal and Reuters. Sample media appearances are here, here and here.

Prior to launching Capitol Street in 2009, Smolinski was the Senior Equity Research Analyst for Healthcare Policy at J.P.Morgan. Before joining J.P.Morgan, Smolinski advised clients on health policy and trends at Citigroup and Bear Stearns. Earlier in her career, she spent several years as a healthcare management consultant at the Lewin Group, a Washington-based firm specializing in managed care and healthcare payment policy, and worked at both Pfizer and the Centers for Disease Control (CDC).

Smolinski holds an MBA and a Masters in Public Health (MPH) from Columbia University and received her BA from the Johns Hopkins University in Baltimore, MD. She published biomedical research findings in otolaryngology at the Johns Hopkins School of Medicine.
Speaking In
10:30 AM - 11:55 AM (EST)
Wednesday, February 17

Both U.S. political parties have proposed changes to the reimbursement process for FDA-approved…